Annual Total Liabilities
$22.61 M
+$734.80 K+3.36%
December 31, 2023
Summary
- As of March 10, 2025, INKT annual total liabilities is $22.61 million, with the most recent change of +$734.80 thousand (+3.36%) on December 31, 2023.
- During the last 3 years, INKT annual total liabilities has fallen by -$35.82 million (-61.31%).
- INKT annual total liabilities is now -61.31% below its all-time high of $58.43 million, reached on December 31, 2020.
Performance
INKT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$24.93 M
-$1.97 M-7.33%
September 30, 2024
Summary
- As of March 10, 2025, INKT quarterly total liabilities is $24.93 million, with the most recent change of -$1.97 million (-7.33%) on September 30, 2024.
- Over the past year, INKT quarterly total liabilities has stayed the same.
- INKT quarterly total liabilities is now -69.07% below its all-time high of $80.59 million, reached on September 30, 2021.
Performance
INKT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
INKT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | 0.0% |
| 3 y3 years | -61.3% | 0.0% |
| 5 y5 years | -39.9% | 0.0% |
INKT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.3% | -8.3% | +51.4% |
| 5 y | 5-year | -61.3% | +37.3% | -69.1% | +51.4% |
| alltime | all time | -61.3% | +37.3% | -69.1% | +51.4% |
MiNK Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.93 M(-7.3%) |
| Jun 2024 | - | $26.90 M(-1.1%) |
| Mar 2024 | - | $27.19 M(+20.3%) |
| Dec 2023 | $22.61 M(+3.4%) | $22.61 M(+7.4%) |
| Sep 2023 | - | $21.04 M(-2.6%) |
| Jun 2023 | - | $21.61 M(+2.6%) |
| Mar 2023 | - | $21.06 M(-3.7%) |
| Dec 2022 | $21.87 M | $21.87 M(+18.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $18.51 M(+6.2%) |
| Jun 2022 | - | $17.43 M(-7.5%) |
| Mar 2022 | - | $18.83 M(+14.4%) |
| Dec 2021 | $16.46 M(-71.8%) | $16.46 M(-79.6%) |
| Sep 2021 | - | $80.59 M(+18.6%) |
| Jun 2021 | - | $67.93 M(+16.3%) |
| Dec 2020 | $58.43 M(+55.2%) | $58.43 M |
| Dec 2019 | $37.64 M | - |
FAQ
- What is MiNK Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for MiNK Therapeutics?
- What is MiNK Therapeutics annual total liabilities year-on-year change?
- What is MiNK Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly total liabilities year-on-year change?
What is MiNK Therapeutics annual total liabilities?
The current annual total liabilities of INKT is $22.61 M
What is the all time high annual total liabilities for MiNK Therapeutics?
MiNK Therapeutics all-time high annual total liabilities is $58.43 M
What is MiNK Therapeutics annual total liabilities year-on-year change?
Over the past year, INKT annual total liabilities has changed by +$734.80 K (+3.36%)
What is MiNK Therapeutics quarterly total liabilities?
The current quarterly total liabilities of INKT is $24.93 M
What is the all time high quarterly total liabilities for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly total liabilities is $80.59 M
What is MiNK Therapeutics quarterly total liabilities year-on-year change?
Over the past year, INKT quarterly total liabilities has changed by $0.00 (0.00%)